Skip to main content
Gabrielle Page-Wilson, MD, Endocrinology, New York, NY, NewYork-Presbyterian/Columbia University Irving Medical Center

GabriellePage-WilsonMD

Endocrinology New York, NY

Diabetes, Gonad Disorders & Reproductive, Obesity, Pituitary Disorders & Neuroendocrinology

Associate Professor of Medicine

Dr. Page-Wilson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Page-Wilson's full profile

Already have an account?

Summary

  • Dr. Gabrielle Page-Wilson is an endocrinologist in New York, NY and is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Harvard Medical School and has been in practice 11 years. She specializes in complex hormonal disorders including pituitary disorders, disorders of reproduction in both men and women, menopause, neuroendocrinology and obesity. She has extensive clinical research experience and has served as a Principal Investigator for NIH funded and sponsored clinical trials. She has over 25 publications and speaks nationally on diverse endocrine topics.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2008
  • Harvard Medical School
    Harvard Medical SchoolClass of 2005
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - 2026
  • NY State Medical License
    NY State Medical License 2008 - 2025
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • PA State Medical License
    PA State Medical License 2024 - 2024
  • CT State Medical License
    CT State Medical License 2022 - 2024
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Treatment of Hyperprolactinemia with the Non-Ergoline Dopamine Agonist Ropinirole
    Treatment of Hyperprolactinemia with the Non-Ergoline Dopamine Agonist RopiniroleJanuary 31st, 2017

Professional Memberships

Hospital Affiliations